About This Study
Focal segmental glomerulosclerosis (FSGS) is a kidney disease that slowly gets worse over time. It damages the tiny filters in the kidneys, causing scars and making the filters leaky. This lets protein leak into the urine. The purpose of this study is to learn more about a new medicine for this disease. Our researchers want to see if it can lower the amount of protein in the urine and help slow kidney damage when taken with a common blood pressure medicine called an ARB.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
- Diary/e-Diary Writing or Recordings
Age & Gender
- 12 - 80 years old
- Female
- Male
Language
- This study enrolls English speakers only
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC